S05403 Summary:

BILL NOS05403
 
SAME ASSAME AS A07582
 
SPONSORBRESLIN
 
COSPNSR
 
MLTSPNSR
 
Add §6808-c, Ed L
 
Requires manufacturer of nonprescription blood glucose self-testing equipment, devices and supplies to submit to the New York State Board of Pharmacy a comprehensive list of designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies; and prohibits pharmacists from distributing nonprescription blood glucose self-testing equipment, devices, and supplies or seeking reimbursement therefor when the pharmacist knows or has reason to know that the equipment did not come through an authorized supplier or distributor.
Go to top    

S05403 Actions:

BILL NOS05403
 
04/29/2019REFERRED TO HIGHER EDUCATION
01/08/2020REFERRED TO HIGHER EDUCATION
Go to top

S05403 Committee Votes:

Go to top

S05403 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S05403 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          5403
 
                               2019-2020 Regular Sessions
 
                    IN SENATE
 
                                     April 29, 2019
                                       ___________
 
        Introduced  by  Sen. BRESLIN -- read twice and ordered printed, and when
          printed to be committed to the Committee on Higher Education
 
        AN ACT to amend the education law, in relation to  designated  suppliers
          and  authorized  distributors  of  nonprescription blood glucose self-
          testing equipment, devices and supplies

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. The education law is amended by adding a new section 6808-c
     2  to read as follows:
     3    §  6808-c.  Suppliers  and  authorized distributors of nonprescription
     4  blood glucose self-testing equipment, devices and supplies. 1.  As  used
     5  in  this section, "nonprescription blood glucose self-testing equipment,
     6  devices and supplies" means blood glucose monitors,  continuous  glucose
     7  monitors  (CGM),  blood glucose test strips, lancet devices and lancets,
     8  glucose control solutions for checking the accuracy of testing equipment
     9  and test strips, supply allowance  for  therapeutic  continuous  glucose
    10  monitors  (CGM),  including  all supplies and accessories for use in the
    11  treatment of prediabetic or diabetic individuals that may be sold  with-
    12  out a prescription and are labeled for use by the consumer in accordance
    13  with the requirements of the laws and rules of this state and the feder-
    14  al government.
    15    2.  Within  one  hundred  eighty  days  of  the effective date of this
    16  section, each manufacturer of nonprescription blood glucose self-testing
    17  equipment, devices and supplies shall submit to the state board of phar-
    18  macy  a  comprehensive  list  of  designated  suppliers  and  authorized
    19  distributors  of  nonprescription  blood glucose self-testing equipment,
    20  devices and supplies. Such manufacturers shall update the state board of
    21  pharmacy when there are any changes to the list of designated  suppliers
    22  and authorized distributors. Within ninety days of receiving that infor-
    23  mation,  such  board  shall  post  the names of designated suppliers and
    24  authorized distributors on the department's website.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11356-01-9

        S. 5403                             2
 
     1    3. It shall be unprofessional conduct for a pharmacist to:
     2    a.  dispense  nonprescription  blood  glucose  self-testing equipment,
     3  devices and supplies received from a person or entity that  the  pharma-
     4  cist  knew  or  reasonably  should  have  known was not a manufacturer's
     5  designated supplier or authorized distributor; or
     6    b. submit a reimbursement  claim  for  nonprescription  blood  glucose
     7  self-testing equipment, devices and supplies to a pharmaceutical benefit
     8  manager,  health  insurer, government agency, or other third-party payor
     9  when the pharmacist knew  or  reasonably  should  have  known  that  the
    10  diabetes test device was not purchased either directly from the manufac-
    11  turer  or from the nonprescription blood glucose self-testing equipment,
    12  devices and supplies manufacturer's designated  supplier  or  authorized
    13  distributor.
    14    § 2. This act shall take effect immediately.
Go to top